Biosimilar approval and adoption in the U.S. needs to be expedited
(By Carlos Sattler and Sheila Frame for STAT) Generic versions of brand-name small-molecule drugs saved Americans more than $1 trillion between 1999
Read morePart D/Prescription Drugs
When medicines are unaffordable, here’s how patients cut costs
(By Megan Thielking for STAT) One in five U.S. adults prescribed medicines say they’ve asked their doctor for a cheaper
Read moreHow the not-for-profit Civica Rx will disrupt the generic drug industry
(By Marc Harrison for STAT) The generic drug industry should cause prices for medications to drop. But lately it has
Read moreTime is running out if you want to change your Medicare Advantage plan
Time is running out if you want to change your Medicare Advantage plan or switch back to original Medicare. You
Read moreFDA approves new generic for valsartan
After multiple recalls of a certain generic valsartan medications, the U.S. Food and Drug Administration has approved a new generic
Read moreLearning the pluses and minuses to Medicare Advantage plans
Medicare Advantage, also known as Medicare Part C, is one of four parts of the Medicare program. Medicare Part C
Read moreHow Much Difference Will Eli Lilly’s Half-Price Insulin Make?
(By Bram Sable-Smith for Kaiser Health News) When Erin Gilmer filled her insulin prescription at a Denver-area Walgreens in January,
Read moreOpioid Litigation Brings Company Secrets Into The Public Eye
(By Brian Mann for NPR) America’s big drugmakers and pharmacy chains are scrambling to respond to hundreds of lawsuits tied
Read moreExpanded drug rebate program to consumers
UnitedHealth, the country’s largest health insurer, announced it would expand a program that passes drug manufacturer rebates directly to consumers
Read moreTrump budget pitches capping seniors’ out-of-pocket drug costs, cutting NIH funding
(Lev Facher for STAT) WASHINGTON — The White House on Monday proposed capping out-of-pocket prescription drug expenses for seniors covered
Read more